The emerging trend in metabolic health is undoubtedly centered around GLP-1 receptor agonists , and BrightMeds is at the forefront of this wave . These groundbreaking drugs, initially created for treating type 2 diabetes, are now widely prescribed – or considered – for their significant ability to promote reduced body fat and improve metabolic